|
|
Biotechnology is having an increasingly important impact on a number of sectors and disciplines. OECD has been working on biotechnology-related topics for over 25 years. These include scientific, industrial, health and agricultural applications. It also has a strong record on safety issues in biotechnology.
What's new
|
from 04-Apr-2008 to 16-May-2008
The OECD is inviting comments on its draft Guidelines for Human Biobanks and Genetic Research Databases, which offer principles and best practices for the establishment, governance, management and use of human biobanks and genetic research databases. The invitation to comment is open to all interested parties. Comments may be submitted until 16 May.
|
|
23-Oct-2007
This publication presents the results of a survey of over 800 genetic testing laboratory directors in 18 OECD countries. It covers questions such as types of laboratory policies and practices in place to assure the quality of human genetic testing and the proficiency of those that carry out such tests. It includes information on policies regarding samples and genetic data handling, as well as the transborder flow of specimens.
|
|
20-Sep-2007
A new issue of the OECD Biotechnology Update has been published. This newsletter provides up-to-date information on the diverse activities at OECD related to biotechnology
|
|
03-Aug-2007
This document addresses the general information concerning the δ-endotoxin genes and their protein toxin products that confer insect protection to plants. The United States served as the lead country in the preparation of this document.
|
|
06-Jul-2007
An OECD workshop was held by the Sub-working Group on Micro-organisms of the OECD Working Group on Harmonisation of Regulatory Oversight in Biotechnology (the Working Group), 20-22 June 2007 at Moscow State University.
|
|
14-Jun-2007
In order to meet modern demands for the further advancement of biotechnology and life sciences, the OECD in 2001 introduced a new concept of repositories and providers of high quality biological materials and information: Biological Resource Centres (BRCs). BRCs are considered to be one of the key elements for sustainable international scientific infrastructure, which is necessary to underpin successful delivery of the benefits of biotechnology, whether within the health sector, the industrial sector or other sectors, and in turn ensure that these advances help drive growth.
|
|
21-May-2007
OECD member countries have adopted an agreed set of Guidelines for Quality Assurance in Molecular Genetic Testing. The Guidelines address genetic testing for variations in germ line DNA sequences or products arising directly from changes in heritable genomic sequences that predict effects on the health, or influence the health management, of an individual. They focus on molecular genetic testing for the diagnosis of a particular disease or condition and predictive genetic testing often carried out before any clinical signs of the disease or condition appear.
|
|
14-Jun-2007
The threat of bioterrorism gives rise to the need to protect facilities that work with, store or transfer dangerous biological material from being intentionally misused for malevolent ends. The OECD Best Practice Guidelines on Biosecurity for BRCs are designed to secure all types of biological materials (e.g. plant-, animal-, micro-organism- and human-derived) in proportion to the risk they present.
|
See more news and events…
Top of page
|
Editor's Choice
Health technology has great potential to change our understanding of disease, transform delivery of health-care services, and improve health outcomes. This book examines how countries can successfully manage the opportunities and challenges arising from developments in health-related technologies and biotechnology.
Health Technologies and Decision Making
|
A free and easy way to receive the latest news releases and media alerts
